Our Vision
The Problem
SARCIO BELIEVES PATIENTS
DESERVE A BETTER OPTION.
Current Patient Pathway vs. the Sarcio Solution
Conservative measures like physical therapy, viscosupplementation (hyaluronic acid injections), and steroid injections may help in the short term. However, these measures often require joint replacements to relieve pain and enable joint function. Although total joint replacements can improve quality of life, recovery is long and painful, and implants only last 15-20 years. This forces many patients to choose between delaying surgery and having multiple surgeries on the same joint. Sarcio is developing an allogenic, iPSC-derived cartilage cell therapy to treat patients with osteoarthritis and delay or prevent the need for joint replacement.
Our Goals
Technology
Sarcio has developed a method to generate high-quality hyaline cartilage cells to provide restoration, regeneration, and repair.
About
Sarcio seeks a groundbreaking, regenerative therapy to restore normal joint function and improve the lives of patients suffering from osteoarthritis.